Blood glucose monitor from Roche gets FDA OK

01/15/2012 | (Boston)

Roche has received FDA clearance for its Accu-Chek Nano SmartView system for monitoring blood glucose. The device, which is targeted for U.S. market launch in the first half of this year, is designed to allow diabetes patients to create personalized test alerts and meal markers, as well as compute their average glucose levels.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ